ArticleThe Journal of experimental medicine2022

Ferrous iron-activatable drug conjugate achieves potent MAPK blockade in KRAS-driven tumors.

Honglin Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.